Ken Griffin 908 Devices Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.45 - $6.17 $45,885 - $82,061	13,300 Added 1662.5%	14,100 $48,000
Q2 2024 Aug 14, 2024	SELL	$5.0 - $7.24 $69,500 - $100,636	-13,900 Reduced 94.56%	800 $4,000
Q1 2024 May 15, 2024	BUY	$6.55 - $9.92 $11,135 - $16,864	1,700 Added 13.08%	14,700 $110,000
Q4 2023 Feb 14, 2024	SELL	$4.96 - $12.41 $26,784 - $67,014	-5,400 Reduced 29.35%	13,000 $145,000
Q3 2023 Nov 14, 2023	BUY	$6.0 - $8.2 $57,600 - $78,720	9,600 Added 109.09%	18,400 $122,000
Q2 2023 Aug 14, 2023	BUY	$5.78 - $10.02 $34,102 - $59,118	5,900 Added 203.45%	8,800 $60,000
Q1 2023 May 15, 2023	BUY	$6.61 - $10.66 $5,949 - $9,594	900 Added 45.0%	2,900 $24,000
Q4 2022 Feb 14, 2023	SELL	$7.0 - $17.96 $102,200 - $262,216	-14,600 Reduced 87.95%	2,000 $15,000
Q3 2022 Nov 14, 2022	SELL	$15.18 - $24.99 $347,622 - $572,271	-22,900 Reduced 57.97%	16,600 $273,000

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $71.4M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.